dihydrocodeine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
886 125-28-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • dihydrocodeine
  • codhydrine
  • cohydrin
  • dehacodin
  • dihydroneopine
  • hydrocodeine
  • hydrocodin
  • dihydrocodeine bitartrate
  • parzone bitartrate
  • dihydrocodeine phosphate
  • Molecular weight: 301.39
  • Formula: C18H23NO3
  • CLOGP: 1.26
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 1
  • TPSA: 41.93
  • ALOGS: -2.10
  • ROTB: 1

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
0.15 g O

ADMET properties:

PropertyValueReference
BA (Bioavailability) 20 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
Vd (Volume of distribution) 1.07 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 4.21 mL/min/kg Lombardo F, Berellini G, Obach RS
t_half (Half-life) 3.42 hours Lombardo F, Berellini G, Obach RS

Approvals:

DateAgencyCompanyOrphan
July 7, 1958 FDA CARACO

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Congenital thrombocytopenia 78.77 24.86 11 2885 44 50602184
Acute kidney injury 75.24 24.86 78 2818 227980 50374248
Toxicity to various agents 63.50 24.86 69 2827 212430 50389798
Neutropenic sepsis 51.54 24.86 22 2874 14125 50588103
Intestinal pseudo-obstruction 50.02 24.86 11 2885 743 50601485
Perforation 47.32 24.86 11 2885 953 50601275
Limbic encephalitis 43.20 24.86 8 2888 225 50602003
Poisoning deliberate 41.53 24.86 16 2880 7896 50594332
Symptom masked 40.19 24.86 9 2887 660 50601568
Pancreatitis chronic 38.22 24.86 11 2885 2209 50600019
Terminal ileitis 35.51 24.86 8 2888 603 50601625
Toxic leukoencephalopathy 35.10 24.86 8 2888 635 50601593
Acquired cystic kidney disease 31.95 24.86 5 2891 49 50602179
Colitis 30.88 24.86 22 2874 38507 50563721
Abnormal loss of weight 29.31 24.86 11 2885 5053 50597175
Colitis ischaemic 28.86 24.86 13 2883 9470 50592758
Peritonitis 28.35 24.86 15 2881 15471 50586757
Large intestine perforation 25.14 24.86 11 2885 7483 50594745

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxicity to various agents 102.26 27.37 88 1917 173573 29398949
Femoral nerve palsy 40.53 27.37 6 1999 32 29572490
Electric shock sensation 32.86 27.37 5 2000 33 29572489
Overdose 30.46 27.37 32 1973 79787 29492735
Upper gastrointestinal haemorrhage 28.46 27.37 18 1987 21896 29550626

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxicity to various agents 124.38 20.61 145 4760 363368 64130459
Acute kidney injury 58.20 20.61 114 4791 449126 64044701
Perforation 42.30 20.61 11 4894 1137 64492690
Abnormal loss of weight 41.53 20.61 17 4888 7383 64486444
Femoral nerve palsy 36.62 20.61 6 4899 59 64493768
Neutropenic sepsis 35.26 20.61 22 4883 23250 64470577
Overdose 33.08 20.61 50 4855 159516 64334311
Limbic encephalitis 32.50 20.61 8 4897 663 64493164
Upper gastrointestinal haemorrhage 31.35 20.61 24 4881 35196 64458631
Toxic leukoencephalopathy 30.03 20.61 8 4897 907 64492920
Acquired cystic kidney disease 29.84 20.61 5 4900 57 64493770
Terminal ileitis 27.83 20.61 7 4898 633 64493194
Premature baby 27.19 20.61 10 4895 3262 64490565
Electric shock sensation 26.78 20.61 6 4899 330 64493497
Poisoning deliberate 26.32 20.61 15 4890 13443 64480384
Pancreatitis chronic 26.30 20.61 10 4895 3576 64490251
Somnolence 25.40 20.61 51 4854 203594 64290233
Faecaloma 25.02 20.61 13 4892 9715 64484112
Tandem gait test abnormal 24.83 20.61 4 4901 35 64493792
Drug ineffective 24.62 20.61 17 4888 840230 63653597
Alcoholic liver disease 24.09 20.61 6 4899 522 64493305
Respiratory depression 23.14 20.61 17 4888 23426 64470401
Overflow diarrhoea 23.05 20.61 4 4901 57 64493770
Colitis ischaemic 21.12 20.61 13 4892 13401 64480426
Cholestasis of pregnancy 20.75 20.61 6 4899 919 64492908

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N02AA08 NERVOUS SYSTEM
ANALGESICS
OPIOIDS
Natural opium alkaloids
ATC N02AA58 NERVOUS SYSTEM
ANALGESICS
OPIOIDS
Natural opium alkaloids
ATC N02AJ01 NERVOUS SYSTEM
ANALGESICS
OPIOIDS
Opioids in combination with non-opioid analgesics
ATC N02AJ02 NERVOUS SYSTEM
ANALGESICS
OPIOIDS
Opioids in combination with non-opioid analgesics
ATC N02AJ03 NERVOUS SYSTEM
ANALGESICS
OPIOIDS
Opioids in combination with non-opioid analgesics
MeSH PA D000700 Analgesics
MeSH PA D000701 Analgesics, Opioid
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D009294 Narcotics
MeSH PA D018373 Peripheral Nervous System Agents
MeSH PA D018689 Sensory System Agents
FDA MoA N0000175684 Full Opioid Agonists
FDA EPC N0000175690 Opioid Agonist

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Pain indication 22253000
Cough indication 49727002
Allergic rhinitis indication 61582004
Nasal discharge indication 64531003
Nasal congestion indication 68235000
Rhinitis indication 70076002 DOID:4483
Common cold indication 82272006 DOID:10459
Necrotizing enterocolitis in fetus OR newborn contraindication 2707005
Ocular hypertension contraindication 4210003 DOID:9282
Suicidal thoughts contraindication 6471006
Dependent drug abuse contraindication 6525002
Alcoholism contraindication 7200002
Alcohol withdrawal delirium contraindication 8635005
Peptic ulcer contraindication 13200003 DOID:750
Chronic obstructive lung disease contraindication 13645005 DOID:3083
Asthenia contraindication 13791008
Constipation contraindication 14760008 DOID:2089
Mood swings contraindication 18963009
Myocardial infarction contraindication 22298006 DOID:5844
Inflammatory bowel disease contraindication 24526004 DOID:0050589
Ventricular tachycardia contraindication 25569003
Alcohol intoxication contraindication 25702006
Shock contraindication 27942005
Hypercapnia contraindication 29596007
Dehydration contraindication 34095006
Hyperthyroidism contraindication 34486009 DOID:7998
Acute hepatitis contraindication 37871000
Hypertensive disorder contraindication 38341003 DOID:10763
Disorder of gallbladder contraindication 39621005 DOID:0060262
Gastrointestinal ulcer contraindication 40845000
Hypothyroidism contraindication 40930008 DOID:1459
Conduction disorder of the heart contraindication 44808001
Low blood pressure contraindication 45007003
Chronic heart failure contraindication 48447003
Bradycardia contraindication 48867003
Acidosis contraindication 51387008
Vitamin K deficiency contraindication 52675005 DOID:11249
Nasal polyp contraindication 52756005
Coronary arteriosclerosis contraindication 53741008 DOID:3393
Acute nephropathy contraindication 58574008
Hepatic failure contraindication 59927004
Ulcerative colitis contraindication 64766004 DOID:8577
Arterial thrombosis contraindication 65198009
Substance abuse contraindication 66214007
Benign intracranial hypertension contraindication 68267002 DOID:11459
Poisoning by acetaminophen contraindication 70273001
Agoraphobia contraindication 70691001 DOID:593
Arteriosclerotic vascular disease contraindication 72092001
Diabetes mellitus contraindication 73211009 DOID:9351
Factor II deficiency contraindication 73975000
Reye's syndrome contraindication 74351001 DOID:14525
Gastrointestinal hemorrhage contraindication 74474003
Urethral stricture contraindication 76618002
Thrombotic thrombocytopenic purpura contraindication 78129009 DOID:10772
Decreased respiratory function contraindication 80954004
Injury of head contraindication 82271004
Chronic idiopathic constipation contraindication 82934008
Cor pulmonale contraindication 83291003 DOID:8515
Pulmonary emphysema contraindication 87433001
Gout contraindication 90560007 DOID:13189
Kidney disease contraindication 90708001 DOID:557
Hemophilia contraindication 90935002
Anemia due to enzyme deficiency contraindication 111577008
Acute abdominal pain contraindication 116290004
Gastrointestinal obstruction contraindication 126765001
Neoplasm of brain contraindication 126952004 DOID:1319
von Willebrand disorder contraindication 128105004 DOID:12531
Seizure disorder contraindication 128613002
Drug-induced psychosis contraindication 191483003 DOID:1742
Obsessive-compulsive disorder contraindication 191736004 DOID:10933
Insomnia contraindication 193462001
Partial atrioventricular block contraindication 195039008
Acute pancreatitis contraindication 197456007 DOID:2913
Impaired renal function disorder contraindication 197663003
Disease of liver contraindication 235856003 DOID:409
Bladder outflow obstruction contraindication 236645006
Morbid obesity contraindication 238136002 DOID:11981
Benign prostatic hyperplasia contraindication 266569009
Retention of urine contraindication 267064002
Anemia contraindication 271737000 DOID:2355
Exacerbation of asthma contraindication 281239006
Pregnancy, function contraindication 289908002
Lesion of brain contraindication 301766008
Thrombocytopenic disorder contraindication 302215000 DOID:1588
Panic disorder contraindication 371631005 DOID:594
Coma contraindication 371632003
Primary adrenocortical insufficiency contraindication 373662000
Operation on gastrointestinal tract contraindication 386621005
Hypoxia contraindication 389086002
Angle-closure glaucoma contraindication 392291006 DOID:13550
Breastfeeding (mother) contraindication 413712001
Disorder of coronary artery contraindication 414024009
Myocardial ischemia contraindication 414795007 DOID:3393
Myocardial infarction in recovery phase contraindication 418044006
Central nervous system depression contraindication 418072004
Dysfunction of sphincter of Oddi contraindication 430887001
Hypertensive urgency contraindication 443482000
Acute erosive gastritis contraindication 444926003




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.22 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Mu-type opioid receptor GPCR AGONIST CHEMBL CHEMBL

External reference:

IDSource
4019720 VUID
N0000147812 NUI
D01481 KEGG_DRUG
5965-13-9 SECONDARY_CAS_RN
104966 RXNORM
4018062 VANDF
4019720 VANDF
C0058056 UMLSCUI
CHEBI:135276 CHEBI
CHEMBL1595 ChEMBL_ID
CHEMBL2062266 ChEMBL_ID
DB01551 DRUGBANK_ID
C014481 MESH_SUPPLEMENTAL_RECORD_UI
5284543 PUBCHEM_CID
7594 IUPHAR_LIGAND_ID
728 INN_ID
24204-13-5 SECONDARY_CAS_RN
N9I9HDB855 UNII
4599 MMSL
d03168 MMSL
001557 NDDF
004420 NDDF
004421 NDDF
322538006 SNOMEDCT_US
387322000 SNOMEDCT_US
57811004 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Acetaminophen, Caffeine, Dihydrocodeine Bitartrate HUMAN PRESCRIPTION DRUG LABEL 3 42195-840 CAPSULE 16 mg ORAL ANDA 28 sections
Dihydrocodeine Bitartrate, Acetaminophen and Caffeine HUMAN PRESCRIPTION DRUG LABEL 3 54868-5900 TABLET 32 mg ORAL ANDA 20 sections
Trezix HUMAN PRESCRIPTION DRUG LABEL 3 63187-705 CAPSULE 16 mg ORAL ANDA 22 sections
Trezix HUMAN PRESCRIPTION DRUG LABEL 3 63187-705 CAPSULE 16 mg ORAL ANDA 22 sections
Trezix HUMAN PRESCRIPTION DRUG LABEL 3 63629-5637 CAPSULE 16 mg ORAL ANDA 22 sections
Trezix HUMAN PRESCRIPTION DRUG LABEL 3 66992-840 CAPSULE 16 mg ORAL ANDA 23 sections
Acetaminophen, Caffeine and Dihydrocodeine Bitartrate HUMAN PRESCRIPTION DRUG LABEL 3 71993-300 TABLET 16 mg ORAL ANDA 27 sections